日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

PCIF1 Attenuates Type I Interferon Induction by Inhibiting IRF3 Activation in a Methyltransferase-Independent Manner

PCIF1通过以不依赖于甲基转移酶的方式抑制IRF3活化来减弱I型干扰素的诱导

期刊:Cells
影响因子:5.2
doi:10.3390/cells15030303
Kano, Ryoya; Oyama, Chihiro; Ikeda, Chihiro; Inujima, Akiko; Koizumi, Keiichi; Akichika, Shinichiro; Suzuki, Tsutomu; Tanaka, Aki; Ohkuma, Yoshiaki; Hirose, Yutaka
IRF3
发表日期：2026
文献求助 收藏

Exploiting nanopore sequencing advances for tRNA sequencing of human cancer models

利用纳米孔测序技术对人类癌症模型进行tRNA测序

期刊:NAR Cancer
影响因子:3.2
doi:10.1093/narcan/zcaf044
Kochavi, Adva; Velds, Arno; Suzuki, Maya; Akichika, Shinichiro; Suzuki, Tsutomu; Beijersbergen, Roderick L; Agami, Reuven
Sequencing
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Comprehensive proteome profiling of molecular endotypes in Japanese adults with moderate-to-severe atopic dermatitis

对患有中重度特应性皮炎的日本成年人进行分子内型的全面蛋白质组学分析

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2025.1649918
Serelli-Lee, Victoria; Ozeki, Akichika; Preuss, Christoph; Benschop, Robert J; Torisu-Itakura, Hitoe; Matsuo, Takashi; Sims, Jonathan T
发表日期：2025
文献求助 收藏

Enhancing Duloxetine With Mirogabalin for Treating Taxane-Induced Peripheral Neuropathy in Advanced Lung Cancer

度洛西汀联合米罗加巴林治疗晚期肺癌紫杉烷类药物引起的周围神经病变

期刊:Cancer Control
影响因子:2.6
doi:10.1177/10732748251353327
Nakajima, Yasuhiro; Kuribayashi, Kozo; Tada, Akio; Nagano, Akichika; Minami, Toshiyuki; Kanehiro, Arihiko; Kijima, Takashi
肺癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Polarization-Switchable Electrochemistry of 2D Layered Bi(2)O(2)Se Bifunctional Microreactors by Ferroelectric Modulation

利用铁电调制实现二维层状Bi(2)O(2)Se双功能微反应器的极化可切换电化学性能

期刊:Nano Letters
影响因子:9.1
doi:10.1021/acs.nanolett.4c03128
Chiang, Chun-Hao; Yu, Chun-Hung; Lu, Yang-Sheng; Yang, Yueh-Chiang; Lin, Yin-Cheng; Chen, Hsin-An; Ho, Sheng-Zhu; Chen, Yi-Chun; Kumatani, Akichika; Chang, Chen; Kuo, Pai-Chia; Shiue, Jessie; Li, Shao-Sian; Chiu, Po-Wen; Chen, Chun-Wei
发表日期：2024
文献求助 收藏

Long-term treatment with lasmiditan in patients with migraine: post hoc analysis of treatment patterns and outcomes from the open-label extension of the CENTURION randomized trial

拉斯米地坦长期治疗偏头痛患者：CENTURION随机试验开放标签扩展研究的治疗模式和结果的事后分析

期刊:Journal of Headache and Pain
影响因子:7.9
doi:10.1186/s10194-024-01745-y
Komori, Mika; Ozeki, Akichika; Tanji, Yuka; Kamiki, Eriko; Krege, John H; Li, Lily Qian; Suzuki, Shiho; Shibata, Mamoru; Takeshima, Takao
偏头痛
神经科学
发表日期：2024
文献求助 收藏

Human DUS1L catalyzes dihydrouridine modification at tRNA positions 16/17, and DUS1L overexpression perturbs translation

人源DUS1L催化tRNA第16/17位二氢尿苷修饰，DUS1L过表达会扰乱翻译。

期刊:Communications Biology
影响因子:5.2
doi:10.1038/s42003-024-06942-8
Jin Matsuura,Shinichiro Akichika,Fan-Yan Wei,Tsutomu Suzuki,Takahiro Yamamoto,Yuka Watanabe,Leoš Shivaya Valášek,Akitake Mukasa,Kazuhito Tomizawa,Takeshi Chujo
Human
表观遗传
DUS1
发表日期：2024
文献求助 收藏

Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study

日本发作性及慢性偏头痛患者停用 Galcanezumab 后的临床评估：一项随机、安慰剂对照试验及开放标签扩展研究的分析

期刊:Neurology and Therapy
影响因子:4.8
doi:10.1007/s40120-024-00602-z
Takeshima, Takao; Doi, Hikaru; Ooba, Satomi; Tanji, Yuka; Ozeki, Akichika; Komori, Mika
偏头痛
神经科学
发表日期：2024
文献求助 收藏

Versatile strategy using vaccinia virus-capping enzyme to synthesize functional 5' cap-modified mRNAs

利用痘苗病毒加帽酶合成功能性5'端加帽mRNA的多功能策略

期刊:Nucleic Acids Research
影响因子:13.1
doi:10.1093/nar/gkad019
Ohno, Hirohisa; Akamine, Sae; Mochizuki, Megumi; Hayashi, Karin; Akichika, Shinichiro; Suzuki, Tsutomu; Saito, Hirohide
微生物学
发表日期：2023
文献求助 收藏

Galcanezumab Efficacy Through the Dosing Interval in Japanese Patients with Episodic Migraine: Post Hoc Analysis of a Phase 2 Randomized Trial

Galcanezumab 治疗日本发作性偏头痛患者在整个给药间隔内的疗效：一项 2 期随机试验的事后分析

期刊:Neurology and Therapy
影响因子:4.8
doi:10.1007/s40120-023-00534-0
Shibata, Mamoru; Nihira, Atsuko; Tanji, Yuka; Ozeki, Akichika; Imagawa, Hideyuki; Komori, Mika
偏头痛
神经科学
发表日期：2023
文献求助 收藏